Omalizumab improves angioedema-related quality of life impairment in chronic spontaneous urticaria patients: Results from the X-ACT study

被引：0
|
作者：
Weller, Karsten [1 ]
Staubach, Petra [2 ]
Metz, Martin [1 ]
Chapman-Rothe, Nadine [3 ]
Sieder, Christian [3 ]
Brautigam, Matthias [3 ]
Maurer, Marcus [1 ]
机构：
[1] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany
[2] Univ Med Ctr, Dept Dermatol, Utrecht, Netherlands
[3] Novartis Pharmaceut, Basel, Switzerland
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
6835
引用
收藏
页码：AB209 / AB209
页数：1
相关论文
共 50 条
  • [1] Omalizumab improves angioedema-related quality of life impairment in chronic spontaneous urticaria patients: results from the X-ACT study
    Weller, K.
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Braeutigam, M.
    Maurer, M.
    ALLERGY, 2017, 72 : 96 - 96
  • [2] Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Braeutigam, M.
    Maurer, M.
    Weller, K.
    ALLERGY, 2018, 73 (03) : 576 - 584
  • [3] Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Braeutigam, M.
    Canvin, J.
    Maurer, M.
    ALLERGY, 2016, 71 (08) : 1135 - 1144
  • [4] Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria
    Finlay, A. Y.
    Kaplan, A. P.
    Beck, L. A.
    Antonova, E. N.
    Balp, M-M
    Zazzali, J.
    Khalil, S.
    Maurer, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (10) : 1715 - 1721
  • [5] Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial (vol 71, pg 1135, 2016)
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Brautigam, M.
    Canvin, J.
    Maurer, M.
    ALLERGY, 2017, 72 (09) : 1430 - 1430
  • [6] Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria
    Metz, Martin
    Bernstein, Jonathan A.
    Gimenez-Arnau, Ana M.
    Hide, Michihiro
    Maurer, Marcus
    Sitz, Karl
    Soong, Weily
    Sussman, Gordon
    Hua, Eva
    Barve, Avantika
    Barbier, Nathalie
    Balp, Maria-Magdalena
    Severin, Thomas
    WORLD ALLERGY ORGANIZATION JOURNAL, 2022, 15 (11):
  • [7] Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey
    Buyukozturk, Suna
    Gelincik, Asli
    Demirturk, Mustafa
    Kocaturk, Emek
    Colakoglu, Bahattin
    Dal, Murat
    JOURNAL OF DERMATOLOGY, 2012, 39 (05): : 439 - 442
  • [8] Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema
    Maurer, M.
    Sofen, H.
    Ortiz, B.
    Kianifard, F.
    Gabriel, S.
    Bernstein, J. A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (06) : 1056 - 1063
  • [9] Does angioedema influence the quality of life in patients with chronic spontaneous urticaria?
    Oles-Krykowska, A.
    Badura-Brzoza, K.
    Brzoza, Z.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 122 (05) : 539 - 541
  • [10] Ligelizumab Improves Dermatology Quality Of Life In Patients With Chronic Spontaneous Urticaria Regardless of Angioedema Status At Baseline
    Soong, Weily
    Bernstein, Jonathan
    Sitz, Karl
    Maurer, Marcus
    Gimenez-Arnau, Ana
    Ortmann, Christine-Elke
    Severin, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB180 - AB180
12345